MedTrace Logo

The PROMISE Survey

NCT06936813 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2026-01-08

No results posted yet for this study

Summary

The PROMISE Survey was developed to systematically assess the real-world experiences, treatment preferences, side effects, and outcomes from both patients and physicians dealing with prolactinomas. The aim is to generate insights that can guide future clinical research and improve individualized care strategies.

Conditions

  • Prolactinoma
  • Pituitary Tumor

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Cihan Atila · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-13
Primary Completion
2026-01-01
Completion
2026-03-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06936813 on ClinicalTrials.gov